SCHEMBL13638538

SCHEMBL13638538

C=C1CC(Nc2nccc(-c3ccc(CCCOC)cc3)n2)CC(C)(C)N1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 8/20 0.38
CDK1 P06493 2/20 0.37
CDK4 P11802 2/20 0.37
CCNA2 P20248 2/20 0.37
CCNE1 P24864 2/20 0.37
CDK2 P24941 2/20 0.37
CCND3 P30281 2/20 0.37
CDK6 Q00534 2/20 0.37
CHUK O15111 1/20 0.36
MAPK8 P45983 1/20 0.35
HDAC8 Q9BY41 2/20 0.35
MAPK13 O15264 2/20 0.35
MAPK12 P53778 2/20 0.35
MAPK11 Q15759 2/20 0.35
MAPK14 Q16539 2/20 0.35
CLK1 P49759 2/20 0.35
CLK2 P49760 2/20 0.35
DYRK1A Q13627 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35
DYRK1B Q9Y463 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638438 0.89 IKBKB (0.39) IKBKBCDK1CDK4CCNA2CDK2
SCHEMBL13638312 0.89 IKBKB (0.39) IKBKBCDK1CDK4CCNA2CDK2
SCHEMBL13638313 0.88 IKBKB (0.39) IKBKBCHUKMAPK8MAPK11MAPK14
SCHEMBL13638679 0.88 IKBKB (0.41) IKBKBCDK1CDK4CCNA2CDK2
SCHEMBL3478295 0.88 IKBKB (0.41) IKBKBCDK1CDK4CCNA2CCNE1
SCHEMBL13638534 0.86 JAK2 (0.39) IKBKBCHUKMAPK8HDAC8
SCHEMBL13638479 0.85 IKBKB (0.40) IKBKBCDK4CDK2CHUKMAPK8
SCHEMBL13638531 0.84 SYK (0.43) IKBKBCHUKMAPK8HDAC8
SCHEMBL13638437 0.84 IKBKB (0.39) IKBKBCDK1CDK4CCNA2CDK2
SCHEMBL13638532 0.84 IKBKB (0.39) IKBKBCDK1CDK4CCNA2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed